Supernus Pharmaceuticals | SUPN - Ebitda





Ebitda Alterar Data
Abbott USD 2.43B 844M 2026-03
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 3.7M 14.78M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 10.29B 1.86B 2026-03
Novo Nordisk DKK 37.36B 2.64B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
United Therapeutics USD 355M 11.1M 2026-06
Xeris Pharmaceuticals USD 12.33M 12.76M 2026-03